BR-cpd7
BR-cpd7 is a PROTAC degrader for fibroblast growth factor receptor FGFR1/2 with DC50 of 10 nM. BR-cpd7 arrests cell cycle, inhibits proliferations of FGFR1/2 aberrant activated tumor cells. (Pink: ligand for target protein FGFR-IN-12 ; Black: linker; Blue: ligand for E3 ligase Thalidomide-NH-CH2-COOH (HY-131717) )
Product Specifications
UNSPSC
12352005
Target
FGFR; PROTACs
Type
Reference compound
Related Pathways
PROTAC; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/br-cpd7.html
Concentration
10mM
Purity
98.01
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
COC1=CC(OC)=C(C(NC(N(C2=CC(NC3=CC=C(C=C3)N4CCN(CC4)C5CCN(CC5)C(CNC6=CC=CC7=C6C(N(C7=O)C8CCC(NC8=O)=O)=O)=O)=NC=N2)C)=O)=C1Cl)Cl
Molecular Formula
C44H47Cl2N11O8
Molecular Weight
928.82
References & Citations
[1]Kong Y, et al., A Selective FGFR1/2 PROTAC Degrader with Antitumor Activity. Mol Cancer Ther. 2024 Jun 10:OF1-OF11.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
PE Linked Monoclonal Antibody to Cystatin 1 (CST1)
PE Linked Monoclonal Antibody to Cystatin 1 (CST1)
PE Linked Monoclonal Antibody to Cystatin 1 (CST1)
PE Linked Monoclonal Antibody to Cystatin 1 (CST1)
PE Linked Monoclonal Antibody to Cystatin 1 (CST1)